LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
25.37%
↑ 302% vs avg
Percentile
P77
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-12.58%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 25.37% |
| Q2 2025 | 28.29% |
| Q1 2025 | -76.79% |
| Q4 2024 | 14.20% |
| Q3 2024 | 33.01% |
| Q2 2024 | 34.01% |
| Q1 2024 | -14.15% |
| Q4 2023 | -60.22% |
| Q3 2023 | -149.39% |
| Q2 2023 | 58.99% |
| Q1 2023 | -71.49% |
| Q4 2022 | 66.41% |
| Q3 2022 | -0.56% |
| Q2 2022 | -4.02% |
| Q1 2022 | -36.21% |
| Q4 2021 | -1.15% |
| Q3 2021 | -11.83% |
| Q2 2021 | -71.02% |
| Q1 2021 | -52.91% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |